Supplements · Metabolic & Cardiometabolic
tree nuts decreases LDL cholesterol
In plain terms: Do tree nuts lower bad cholesterol?
Yes, well-established across pooled human trials, though they don't change blood sugar.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Tree nuts (almond, cashew, etc.) lower LDL and ApoB; glycemic parameters are largely unaffected (their per-slice GI benefit is carb-dilution, not intrinsic glucose-lowering). Bakeable & premium-positioned; allergen labeling.
The evidence (18)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Nijssen 2024 · Nutrients | RCT | tested-null | moderate | Longer-term mixed-nut intake reduced total & LDL-cholesterol and LDL particle concentrations in older overweight adults. |
| De Lira-Garcia 2012 · Nutr Hosp | meta-analysis | mixed | low | SR of long-term nut/seed/oil consumption: inconsistent effects on lipids; some LDL reduction, heterogeneous. |
| Nora 2023 · Nutr Metab Cardiovasc Dis | RCT | tested-null | low | 42.5g/day mixed nuts lowered LDL-C and Lp(a) in overweight/obese adults vs control. |
| Rajaram 2021 · Circulation | RCT | supports | high | WAHA 2-yr RCT: daily walnuts lowered LDL-C and improved lipoprotein subclasses in healthy elders. |
| Rees 2019 · Cochrane Database Syst Rev | meta-analysis | mixed | high | Mediterranean diet (nut-inclusive) trials: modest LDL/lipid benefits; nut-specific effect not isolated, evidence limited. |
| Musa-Veloso 2025 · Nutrients | meta-analysis | supports | high | SR/MA of RCTs: almond consumption reduces total & LDL cholesterol; ApoB/ApoB:ApoA effects characterized. |
| Lazzarin T et al 2025 · study_type: observational | observational | supports | low | CKD systematic review (4 studies, n=1270): walnuts reduced LDL cholesterol and blood pressure; moderate-to-high risk of bias in included studies |
| Jia Y et al 2024 · study_type: meta-analysis | meta-analysis | mixed | low | MA of 7 CHD studies (n=324): almond intake ↓TC -15.53 mg/dL (95%CI -21.97,-9.1) and ↓LDL -14.62 mg/dL (95%CI -20.92,-8.33), p<0.00001 |
| Guadagni AJ et al 2026 · study_type: RCT | RCT | supports | moderate | Pecan RCT (n=102): 13%/20% energy-dose groups ↓LDL -12.7 to -12.9 mg/dL vs no change in control/low-dose (P<0.05); dose-dependent, no CI given |
| Jenkins 2018 · Diabetologia | RCT | supports | moderate | Replacing dietary carbohydrate with mixed nuts lowered LDL-C and improved CVD risk factors in T2D (reanalysis). |
| Del Gobbo 2015 2015 · Am J Clin Nutr | meta-analysis | supports | high | 61-RCT dose-response: tree nuts lower LDL-C, TC, ApoB |
| Guasch-Ferre 2023 · Nutrients | observational | supports | moderate | Comprehensive review of 19 MAs: total & tree nuts consistently lower LDL-C (-0.09 to -0.26 mmol/L) and TC. |
| Houston 2023 · Adv Nutr | meta-analysis | supports | moderate | SR/MA of RCTs: tree nut & peanut consumption improves CVD risk factors incl. lowering LDL cholesterol. |
| Martínez-Ortega IA et al] # corrected 2026-08-17 from PubMed; was [(network MA 76 RCTs) 2025 · (NMA) | meta-analysis | supports | high | NMA 76 RCTs: all nuts benefit >=1 lipid (cashew best LDL); glycemic params unaffected |
| Liu 2020 2020 · Am J Clin Nutr | meta-analysis | supports | high | network MA: all tree-nut types reduce LDL-C/TC |
| Vilela DLS et al 2024 · study_type: meta-analysis | meta-analysis | tested-null | low | MA of 10 RCTs, nuts (28-84g/d) added to energy-restriction diets: no differential effect on LDL-c vs control (null in ER context) |
| Wong HY et al 2025 · study_type: meta-analysis | meta-analysis | supports | moderate | MA of 115 RCTs (109 meta-analyzed): nut consumption significantly reduced LDL-C, TC, VLDL-C, non-HDL-C, ApoB; no effect on HDL-C or BP |
| Hadi 2023 · Crit Rev Food Sci Nutr | meta-analysis | supports | high | SR/MA of 12 RCTs: pistachio consumption lowered TC, LDL-C and TG in adults. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.